Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 21, 2023
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
[ Thu, Sep 21st 2023
] - WOPRAI
Michael Okunewitch Initiated (ANEB) at Strong Buy and Held Target at $6 on, Sep 21st, 2023
Michael Okunewitch of Maxim Group, Initiated "Anebulo Pharmaceuticals, Inc." (ANEB) at Strong Buy and Held Target at $6 on, Sep 21st, 2023.
Michael has made no other calls on ANEB in the last 4 months.
There is 1 other peer that has a rating on ANEB. Out of the 1 peers that are also analyzing ANEB, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $6 on, Monday, September 18th, 2023
